Michael Dial
SelectiveNamed in filings at Hatteras Venture PartnersOn the current fund
- Board seats filed
- 7
- Named on a board
all filings on record
Named in filings at Hatteras Venture PartnersOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Hatteras CREATE SF SPV | Not yet classified | March 2026 | None on file |
| Altis Biosystems | Not yet classified | March 2025 | None on file |
| Atsena Therapeutics | Biotech & pharma | April 2020 | Capra CLO Founders, Sofinnova Venture Partners |
| StrideBio | Not yet classified | June 2018 | None on file |
| Ribometrix | Biotech & pharma | October 2017 | SV Life Sciences, Virtuoso-mccarran |
| KinoDyn | Not yet classified | June 2014 | None on file |
| Curoverse | Biotech & pharma | August 2013 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Michael Dial on the board, based on 3 filed seats with a verified or cited source.
4 more filed seats not yet classified, left out of the shares above.